Northwestern Medicine investigators have continued to examine COVID-19, from the impact of prone positioning during treatment to vaccine protection against the Omicron variant in children.
Browsing: Will Doss
A newly discovered inhibitor of a common cancer-causing protein operates selectively, reducing expression of genes that fuel rampant cell proliferation, and altering the epigenome, according to a recent study.
Medical student Rohan Chalasani recently won the Mack Lipkin, Sr. Award from the Society of General Internal Medicine at the society’s annual meeting.
A new androgen biosynthesis inhibitor drug improved progression-free survival in prostate cancer but did not improve overall survival compared to current therapies.
Dozens of faculty members and fourth-year medical students were recognized for their scholarly and clinical excellence at Feinberg’s Honors Day, held May 20.
A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung cancer.
Rohail Memon, a second-year medical student, used his finance background to investigate the rise of private equity ownership in dermatology practice.
Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.
A transcription factor associated with androgen receptor activity in prostate cancer has a newly discovered role in controlling lipid biosynthesis.
The Mesulam Center for Cognitive Neurology and Alzheimer’s Disease held the 28th annual Alzheimer Day on May 5, returning to campus for the first time in three years.